Kazia Therapeutics Ltd (KZIA)

NASDAQ

$13.55

Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.

Website: https://www.kaziatherapeutics.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Strong Buy

Target: $27.66 (+104.13%)

Market Cap

$98M

Beta (5Y)

1.47

Price Chart

Adjust inflation

Log

Valuation

Market Cap$98M

Forward P/E12.82

PEG1.01

P/S53.44

P/B4.25

Profitability

Total Revenue (TTM)$1.83M

Gross Profit (TTM)$1.90M

EBITDA-$13M

Operating Margin-268.4%

EPS-$14.35

Growth & Risk

Beta (5Y)1.47

Sharpe Ratio0.77